No abstract available.
Gram-Positive Cocci* ; Imipenem* ; Ofloxacin*

No abstract available.
Autoantibodies* ; Humans

No abstract available.
DNA* ; Hemophilia A* ; Polymerase Chain Reaction*

No abstract available.

BACKGROUND: The purpose of our study is to evaluate the usefulness of cervicovaginal fetal fibronectin assay for the prediction of rupture of membrane and preterm labor. METHODS: A group of 39 pregnant women was involved in this prospective study. Out of 139 pregnant women, 96 were clinically diagnosed as ruptured membranes (group A). The remaining 43 of 139 pregnant women were clinically diagnosed as preterm labor(group B). The assay was performed by using the ROMCheckTM kit (Adeza Biomedical Corp., Sunnyvale, CA). RESULTS: In group 4, fetal fibronectin (fFN) positive rate is 55% (53 patients) and negative rate is 45% (43 patients). In group B, fFN positive rate is 56% (24 patients) and negative rate is 44% (19 patients). Both group of fFN positive patients show a significantly shorter interval from sampling to delivery than fFN negative patients. Also in group A, the percentage of fFN positive patients who delivered at less than 48 hours after sampling is greater than those with fFN negative patients and in group B, the preterm delivery rate is 79% with positive fFN and 37% with negative fFN. As a predictor for preterm delivery, the presence of fFN has the sensitivity 79%, the specificity 84%, the positive Predictive value 76% and the negative predictive value 86%. CONCLUSIONS: The result suggests that a positive fFN in pregnant women who have uterine contractions and ruptured membrane indicates a significant risk for preterm delivery and labor onset, and a negative fFN is a reassuring sign.
Female ; Fibronectins* ; Humans ; Labor Onset ; Membranes ; Obstetric Labor, Premature ; Pregnancy ; Pregnant Women* ; Prospective Studies ; Rupture ; Sensitivity and Specificity ; Uterine Contraction

No abstract available.
Humans ; Liver Cirrhosis* ; Liver* ; Sepsis* ; Vibrio cholerae* ; Vibrio*

No abstract available.
Blood Platelets* ; Disseminated Intravascular Coagulation* ; Platelet Activation*

No abstract available.
Blood Donors* ; Hepacivirus* ; Hepatitis C* ; Hepatitis* ; Humans

No abstract available.
Antibodies*

The clinical bacteriology laboratory has to be prepared to isolate and identify anaerobes as the implication of anaerobes in clinical infections is increasing. Although many types of thioglycollate media have been widely used for the enrichment growth of anerobes, different types are known to have different growth supporting ability. GAM is a recently developed medium, which is said to support a good growth of anaerobes. This study was made to compare GAM and the commonly used thioglycollate medium. It was found that BTM was superior to FTM, but GAM was showing the heaviest growth after a short incubation time. Hemoglobin powder added to FTM or BTM greatly improved growth of Bacteroides without impairing the clarity of the media. Supplementation of FTM with 1/4 strength each of BHI and TSB, and 1000 mg of hemoglobin per liter of medium improved growth of anaerobes. Among all of the tested media, GAM gave the best results for the cultivation of anaerobes including Bacteroides and Fusobacterium.
Anaerobiosis ; Bacteria/growth & development* ; Comparative Study ; Culture Media* ; Hemoglobins ; Thioglycolates*